📗 NEW ISSUE! With Review articles on probiotics as a novel neuroprotective strategy for Alzheimer's and effectively measuring subtle cognitive changes in the presymptomatic stages of Alzheimer's
Read more: https://t.co/H82ZkbNTfF
#alzheimers#Adresearch#alzheimersresearch
🗓�� Webinar: Wednesday 17 June
Join our Editor-in-Chief George Perry for an engaging webinar on Mastering the Neurology Publication Journey: From Submitting to Publishing your Research.
🔗 Register here to advance your research career: https://t.co/1PQEYlkp3d
💡 Spotlighting our Editor's Choice Collection, articles hand-selected by Editor-in-Chief Dr. George Perry to engage and inform the JAD community.
Explore Editor's Choice articles here: https://t.co/wtNwC7nkKY
Sex differences in cognitive performance are not observed in Alzheimer's disease but are observed among individuals with normal cognition, according to results of a study published in JAD.
Read more: https://t.co/9KpPJDt5Eh
#alzheimers#Alzheimersdisease#ADresearch
#AAIC26 is a hub of scientific energy — and a catalyst for progress — uniting the world’s brightest minds in Alzheimer’s and dementia science and clinical practice. Take advantage of early-bird registration prices now until tomorrow, May 15: https://t.co/jdq5rLZXlI.
Causes of death in patients with dementia: A study in a geriatric hospital in São Paulo, Brazil - Yngrid Dieguez Ferreira, Carolina Braga Moura, Amanda Carneiro Rodrigues, Anderson Matheus Pereira Da Silva, Diogo Haddad Santos, Maria Fernanda Mendes, 2026
https://t.co/KMVICXEl4i
@journal_ad@alzforum
Now in press in the Journal of Alzheimer’s Disease: “Methodological considerations on the network meta-analysis of brexpiprazole dosing for agitation in Alzheimer’s disease.”
In this Letter, we discuss relevant methodological and clinical aspects for interpreting a network meta-analysis of different brexpiprazole doses for the management of agitation associated with Alzheimer’s disease.
@DiogoHaddad@journal_ad
https://t.co/dohh9BPKKN
📗 NEW ISSUE!
🫀 Featuring a Review article on the combined role of brain waves (EEG) and heart-rate variability in Alzheimer's disease diagnosis and management.
➡️ Explore the issue: https://t.co/oQIiWaYlIk
#alzheimers#Adresearch#alzheimersresearch
💡 Case study published in JAD Reports demonstrates that an oral antibiotic regimen can reverse key biological markers associated with Alzheimer's disease in a patient with chronic Lyme disease.
Read more: https://t.co/cy9v6aSdYi
#alzheimers#alzheimersdisease#Adresearch
💡New issue! Featuring Review articles on decoding the mechanisms of amyloid-β in synaptic toxicity, experiences of times without care and encounters in dementia, and more.
Explore the issue: https://t.co/arVn7RsajW
#alzheimers#alzheimersdisease#dementiaresearch
Congratulations to Dr. Barbara Mendez Campos Love! Her research on caregiving-related employment disruptions was recently published in the Journal of Alzheimer's Disease:
https://t.co/DvKfYKfIPB
🗓️ Webinar: Friday 24th April
Join JAD's Editor-in-Chief George Perry, Prevention Editor Dharma Singh Khalsa, and @PreventAD to discuss how air pollution is now a major risk factor for Alzheimer’s disease.
Sign up free at: https://t.co/S39rua5QoH
#alzheimers#Adresearch
A new @WesternU study in JAD finds that the brief digital screener built from two @trycreyos cognitive tasks can identify individuals at risk for cognitive impairment in minutes.
Read more: https://t.co/dq0xFe6WjZ
New Supplement Issue from @journal_ad now live: Sensory Loss in Alzheimer’s Disease and Related Dementias. Explore research on sensory changes and their role in dementia.
https://t.co/VdfKW52IRM
#AlzheimersResearch#DementiaResearch#Neuroscience
📗 New issue alert! Featuring Review articles on views on dementia among informal caregivers, evidence integration of acupuncture for prevention and treatment of Alzheimer’s disease, and more.
Read here: https://t.co/Q1HniP9aBS
#alzheimers#alzheimersdisease#ADresearch